Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 7
1995 3
1996 2
1997 6
1998 5
1999 10
2000 11
2001 14
2002 16
2003 14
2004 12
2005 14
2006 22
2007 19
2008 26
2009 22
2010 24
2011 26
2012 27
2013 23
2014 25
2015 23
2016 28
2017 36
2018 32
2019 36
2020 28
2021 18
Text availability
Article attribute
Article type
Publication date

Search Results

472 results
Results by year
Filters applied: . Clear all
Page 1
Cutaneous angiosarcoma: a current update.
Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP. Shustef E, et al. Among authors: prieto vg. J Clin Pathol. 2017 Nov;70(11):917-925. doi: 10.1136/jclinpath-2017-204601. Epub 2017 Sep 15. J Clin Pathol. 2017. PMID: 28916596 Review.
Melanoma pathology reporting and staging.
Scolyer RA, Rawson RV, Gershenwald JE, Ferguson PM, Prieto VG. Scolyer RA, et al. Among authors: prieto vg. Mod Pathol. 2020 Jan;33(Suppl 1):15-24. doi: 10.1038/s41379-019-0402-x. Epub 2019 Nov 22. Mod Pathol. 2020. PMID: 31758078 Review.
Post-radiation vascular lesions of the breast.
Ronen S, Ivan D, Torres-Cabala CA, Curry JL, Tetzlaff MT, Aung PP, Nagarajan P, Suster S, Prieto VG. Ronen S, et al. Among authors: prieto vg. J Cutan Pathol. 2019 Jan;46(1):52-58. doi: 10.1111/cup.13363. Epub 2018 Nov 4. J Cutan Pathol. 2019. PMID: 30251277 Review.
Unusual cutaneous metastatic carcinoma.
Ruiz SJ, Al Salihi S, Prieto VG, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Aung PP. Ruiz SJ, et al. Among authors: prieto vg. Ann Diagn Pathol. 2019 Dec;43:151399. doi: 10.1016/j.anndiagpath.2019.08.003. Epub 2019 Aug 12. Ann Diagn Pathol. 2019. PMID: 31675677 Review.
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.
Roh W, Chen PL, Reuben A, Spencer CN, Prieto PA, Miller JP, Gopalakrishnan V, Wang F, Cooper ZA, Reddy SM, Gumbs C, Little L, Chang Q, Chen WS, Wani K, De Macedo MP, Chen E, Austin-Breneman JL, Jiang H, Roszik J, Tetzlaff MT, Davies MA, Gershenwald JE, Tawbi H, Lazar AJ, Hwu P, Hwu WJ, Diab A, Glitza IC, Patel SP, Woodman SE, Amaria RN, Prieto VG, Hu J, Sharma P, Allison JP, Chin L, Zhang J, Wargo JA, Futreal PA. Roh W, et al. Among authors: prieto vg. Sci Transl Med. 2017 Mar 1;9(379):eaah3560. doi: 10.1126/scitranslmed.aah3560. Sci Transl Med. 2017. PMID: 28251903 Free PMC article.
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.
Tetzlaff MT, Messina JL, Stein JE, Xu X, Amaria RN, Blank CU, van de Wiel BA, Ferguson PM, Rawson RV, Ross MI, Spillane AJ, Gershenwald JE, Saw RPM, van Akkooi ACJ, van Houdt WJ, Mitchell TC, Menzies AM, Long GV, Wargo JA, Davies MA, Prieto VG, Taube JM, Scolyer RA. Tetzlaff MT, et al. Among authors: prieto vg. Ann Oncol. 2018 Aug 1;29(8):1861-1868. doi: 10.1093/annonc/mdy226. Ann Oncol. 2018. PMID: 29945191 Free PMC article.
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy.
Curry JL, Tetzlaff MT, Nagarajan P, Drucker C, Diab A, Hymes SR, Duvic M, Hwu WJ, Wargo JA, Torres-Cabala CA, Rapini RP, Prieto VG. Curry JL, et al. Among authors: prieto vg. J Cutan Pathol. 2017 Feb;44(2):158-176. doi: 10.1111/cup.12858. Epub 2016 Dec 21. J Cutan Pathol. 2017. PMID: 27859479 Review.
NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.
Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D, Prieto VG, Rosenberg A, Treister N, Washington K, Ziemer M, Pavletic SZ, Lee SJ, Flowers ME, Schultz KR, Jagasia M, Martin PJ, Vogelsang GB, Kleiner DE. Shulman HM, et al. Among authors: prieto vg. Biol Blood Marrow Transplant. 2015 Apr;21(4):589-603. doi: 10.1016/j.bbmt.2014.12.031. Epub 2015 Jan 29. Biol Blood Marrow Transplant. 2015. PMID: 25639770 Free PMC article.
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. Ai D, et al. Among authors: prieto vg. Mod Pathol. 2021 Apr;34(4):710-719. doi: 10.1038/s41379-020-00692-8. Epub 2020 Oct 3. Mod Pathol. 2021. PMID: 33011748
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Siroy AE, et al. Among authors: prieto vg. J Invest Dermatol. 2015 Feb;135(2):508-515. doi: 10.1038/jid.2014.366. Epub 2014 Aug 22. J Invest Dermatol. 2015. PMID: 25148578 Free PMC article.
472 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page